Chronic fatigue syndrome (CFS)/Myalgic Encephalomyelitis (ME) and Fibromyalgia (FM): the foundation of a relationship

Abstract

Introduction:

Chronic fatigue syndrome (CFS)/Myalgic Encephalomyelitis (ME) and fibromyalgia (FM) are both debilitating syndromes with complex polysymptomatology. Early research infers that a relationship may exist even though the diagnosis provided may influence the management trajectory. In the absence of a diagnostic test and treatment, this study aims to confirm the symptoms and their severity, which may infer a relationship and influence future research.

Method:

A quasi-experimental design was utilised, using Internet-based self-assessment questionnaires focusing on nine symptom areas: criteria, pain, sleep, fatigue, anxiety and depression, health-related quality of life, self-esteem and locus of control. The questionnaires used for data collection are as follows: the American Centre for Disease Control and Prevention Symptom Inventory for CFS/ME (American CDC Symptom Inventory); the American College of Rheumatology (ACR) Criteria for FM; Fibromyalgia Impact Questionnaire (FIQ); McGill Pain Questionnaire (MPQ); Multidimensional Fatigue Inventory (MFI); Pittsburgh Sleep Quality Index (PSQI); Health-Related Quality of Life SF-36 V2 (HRQoL SF-36 V2); Hospital Anxiety and Depression Scale (HADS); Multidimensional Health Locus of Control (MHLOC) and the Rosenberg Self-Esteem Scale (RSES).

Setting and participants:

Participants were recruited from two distinct community groups, namely CFS/ME (n = 101) and FM (n = 107). Participants were male and female aged 17 (CFS/ME mean age 45.5 years; FM mean age 47.2 years).

Results:

All participants in the CFS/ME and FM groups satisfied the requirements of their individual criteria. Results confirmed that both groups experienced the debilitating symptoms measured, with the exception of anxiety and depression, impacting on their quality of life. Results suggest a relationship between CFS/ME and FM, indicating the requirement for future research.

Keywords

Chronic Fatigue Syndrome chronic pain fatigue Fibromyalgia health-related quality of life musculoskeletal pain Myalgic Encephalomyelitis pain sleep

Get full access to this article

View all access options for this article.

References

Romano

Tomassi

Russell

, et al. Fibromyalgia and chronic fatigue syndrome: the underlying biology and related theoretical issues. Adv Psychosom Med 2015; 34: 61–77.

Wolfe

Clauw

Fitzcharles

, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62(5): 600–610.

Action for ME. Ignorance, injustice and neglect: an investigation into NHS specialist services provision for people with ME/CFS, 2012

Johnston

Brenu

Staines

, et al. The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. Ann Epidemiol 2013; 23(6): 371–376.

Martinez-Lavin

Infante

Lerma

. Hypothesis: the chaos and complexity theory may help our understanding of fibromyalgia and similar maladies. Semin Arthritis Rheum 2008; 37(4): 260–264.

Fukuda

Straus

Hickie

, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121(12): 953–959.

Wolfe

Smythe

Yunus

, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatol 1990; 33: 160–172.

National Institute for Health and Clinical Excellence 53. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children. London: NICE, 2007.

Goldenburg

Simms

Geigen

, et al. High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis Rheumatol 1990; 33: 381–387.

10.

Norregaard

Bulow

Prescott

, et al. A four-year follow-up study in fibromyalgia relationship to chronic fatigue syndrome. Scand J Rheumatol 1993; 22(1): 35–38.

11.

Sullivan

Smith

Buchwald

. Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med 2002; 32(5): 881–888.

12.

Mehendale

Goldman

. Fibromyalgia syndrome, idiopathic widespread persistent pain or syndrome of myalgic encephalomyelopathy (SME): what is its nature? Pain Pract 2002; 2(1): 35–46.

13.

Geisser

Gracely

Giesecke

, et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 2007; 11(2): 202–207.

14.

Kop

Lyden

Berlin

, et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum 2005; 52: 269–303.

15.

Weir

Harlan

Nkoy

, et al. The incidence of fibromyalgia and its associated comorbidities: a population based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 2006; 12: 124–128.

16.

Wessely

Chalder

Hirsch

, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449–1455.

17.

Wagner

Nisenbaum

Heim

, et al. Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr 2005; 3: 8, https://www.ncbi.nlm.nih.gov/pubmed/16042777 (accessed 12 October 2008).

18.

Vermeulen

RCW

. Translation and validation of the Dutch language version of the CDC Symptom Inventory for assessment of chronic fatigue syndrome (CFS). Popul Health Metr 2006; 4: 12.

19.

Hawk

Jason

Torres-Harding

. Reliability of a chronic fatigue syndrome questionnaire. J. Chronic Fatigue Syndr 2006; 13: 41–66.

20.

Bennett

. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development current version operating characteristics and uses clinical and experimental. Rheumatol 2005; 23: 154–162.

21.

Burckhardt

Clark

Bennett

. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 728–733.

22.

Meenan

Gertman

Mason

. Measuring health status in arthritis. The Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23(2): 146–152.

23.

Melzack

. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1(3): 277–299.

24.

Ngamkham

Vincent

Finnegan

, et al. The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review. Pain Manag Nurs 2012; 13(1): 27–51.

25.

Smets

Garssen

Bonke

, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39(3): 315–325.

26.

Lin

Brimmer

Maloney

, et al. Further validation of the Multidimensional Fatigue Inventory in a US adult population. Popul Health Metr 2009; 7: 18, www.pophealthmetrics.com/content/7/1/18

27.

Buysse

Reynolds

III Monk

, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28(2): 193–213.

28.

Smith

Wegner

. Measures of sleep. The Insomnia Severity Index, Medical Outcomes Study (MOS) Sleep Scale, Pittsburgh Sleep Diary (PSD) and Pittsburgh Sleep Quality Index (PSQI). Arthritis and Rheum 2003; 49: 184–196.

29.

Veiga

Cunali

Bonotto

, et al. Sleep quality in patients with temporomandibular disorder: a systematic review. Sleep Sci 2013; 6: 120–124.

30.

Burckhardt

Clark

Bennett

. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993; 20(3): 475–479.

31.

Ware

Jr Kosinski

Gandek

, et al. The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA project. J Clin Epidemiol 1998; 51(11): 1159–1165.

32.

Perrot

Vicaut

Servant

, et al. Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: the DEFI Study (determination of epidemiology of fibromyalgia). BMC Musculoskelet Disord 2011; 12: 224, https://www.ncbi.nlm.nih.gov/pubmed/21981821

33.

Ware

Jr Sherbourne

. The MOS 36-item Short-Form Health Survey (SF-36): I conceptual framework and item selection. Med Care 1992; 30(6): 473–483.

34.

Zigmond

Snaith

. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370.

35.

Bjelland

Dahl

Haug

, et al. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52(2): 69–77.

36.

McCue

Martin

Buchanan

, et al. An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in individuals with chronic fatigue syndrome. Psychol Health Med 2003; 8(4): 425–439.

37.

Wallston

Stein

Smith

. Form C of the MHLC scales a condition-specific measure of locus of control. J Pers Assess 1994; 63(3): 534–553.

38.

Michielsen

Van Houdenhove

Leirs

, et al. Depression, attribution style and self-esteem in chronic fatigue syndrome and fibromyalgia patients: is there a link? Clin Rheumatol 2006; 25(2): 183–188.

39.

White

Schweitzer

. The role of personality in the development and perpetuation of chronic fatigue syndrome. J Psychosom Res 2010; 48: 515–524.

40.

Sinclair

Blais

Gansler

, et al. Psychometric properties of the Rosenberg Self-Esteem Scale: overall and across demographic groups living within the United States. Eval Health Prof 2010; 33(1): 56–80.

41.

Martin

Thompson

Chan

. An examination of the psychometric properties of the Rosenberg Self Esteem Scale (RSES) in Chinese acute Coronary Syndrome (ACS). Psychol Health Med 2006; 11(4): 507–521.

42.

Rosenberg

. Society and the adolescent self-image. Princeton, NJ: Princeton University Press, 1965.

43.

Bennett

Bushmakin

Cappelleri

, et al. Minimal important difference in the Fibromyalgia Impact Questionnaire. J Rheumatol 2009; 36: 1304–1311.

44.

Wallston

DeVellis

. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr 1978; 6(2): 160–170.

45.

Wilkie

Huang

Reilly

, et al. Norrciceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage 2001; 22: 899–910.

46.

Marshall

Paul

McFadyen

, et al. Pain characteristics of people with chronic fatigue syndrome. J Musculoskelet Pain 2010; 18: 127–137.

47.

Stewart

Hays

Ware

Jr.

The MOS short Form General Health Survey: reliability and validity in a patient population. Med Care 1988; 26(7): 724–735.

48.

Snaith

. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003; 1: 29, https://www.ncbi.nlm.nih.gov/pubmed/12914662 (accessed 25 May 2014).

49.

Friedberg

Jason

. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment. J Clin Psychol 2001; 57(4): 433–455.

50.

Vincent

Lahrm

Wolfe

, et al. Prevalence of fibromyalgia: a population-based study in Olmstead County, Minnesota, utilising the Rochester Epidemiology Project. Arthritis Care Res 2013; 65: 286–792.

51.

Craggs-Hinton

. Living with fibromyalgia (Overcoming Common Problems). New ed. London: Sheldon Press, 2010.

52.

Hauser

Wolfe

. Diagnosis and diagnostic tests for fibromyalgia (syndrome). Reumatismo 2012; 64(4): 194–205.

53.

Mease

Palmer

Wang

. Effects of Malcipran on the multidimensional aspects of fatigue to pain and function pooled analysis of 3 fibromyalgia trials. J Clin Rheumatol 2014; 20: 195–202.

54.

Wilkie

Savedra

Holzemer

, et al. Use of the McGill Pain Questionnaire to measure pain: a meta-analysis. Nurs Res 1990; 39(1): 36–41.

55.

Pirins

Van der Meer

Bleijenberg

. Chronic fatigue syndrome. Lancet 2006; 367: 346–355.

56.

Lowry

Pakenham

. Health related quality of life in chronic fatigue syndrome: predictors of physical functioning and psychological distress. Psychol Health Med 2008; 13(2): 222–238.

57.

Nunez

Fernandez-Sola

Nunez

, et al. Health related quality of life in patients with chronic fatigue syndrome: group cognitive behavioral therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year follow up. Clin Rheumatol 2011; 30: 381–389.